产品名称：Anti-Apolipoprotein E4抗体

Cat. Number:

YB5038R

Quantity size:

0.1ml

Concentration:

Anti-Apolipoprotein E4抗体1mg/ml   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Anti-Apolipoprotein E4抗体Apolipoprotein E, a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. ApoE exists in three major isoforms; E2, E3, and E4, which differ from one another by a single amino-acid substitution. Compared with E3 and E4, E2 exhibits the lowest receptor binding affinity. Defects in ApoE are a cause of hyperlipoproteinemia type III due to increased plasma cholesterol and triglycerides levels which are the consequence of impaired clearance of chylomicron and VLDL remnants.
Summary: Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver. Apolipoprotein E, a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells. ApoE is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. The APOE gene is mapped to chromosome 19 in a cluster with APOC1 and APOC2. Defects in apolipoprotein E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. [provided by RefSeq, Jul 2008].

Also known as:

Anti-Apolipoprotein E4抗体APOE4; Apolipoprotein E4; AD2; Alzheimer disease 2 (APOE*E4 associated, late onset); Apo E4; APOE; apoe4; Apolipoprotein E; Apolipoprotein E3; LDLCQ5; LPG; MGC1571.

Specificity:

Storage:

Anti-Apolipoprotein E4抗体Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

Anti-Apolipoprotein E4抗体WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.yb195Hu01 Ⅲ型胶原α1(COL3α1)多克隆抗体 Polyclonal Antibody to Collagen Type III Alpha 1 (COL3a1) Homo sapiens (Human)
yb195Ra01 Ⅲ型胶原α1(COL3α1)多克隆抗体 Polyclonal Antibody to Collagen Type III Alpha 1 (COL3a1) Rattus norvegicus (Rat)
yb196Hu01 转运蛋白2(TNPO2)多克隆抗体 Polyclonal Antibody to Transportin 2 (TNPO2) Homo sapiens (Human)
yb198Hu01 死骨片1(SQSTM1)多克隆抗体 Polyclonal Antibody to Sequestosome 1 (SQSTM1) Homo sapiens (Human)
yb202Mu01 染色质域解旋酶DNA结合蛋白4(CHD4)多克隆抗体 Polyclonal Antibody to Chromodomain Helicase DNA Binding Protein 4 (CHD4) Mus musculus (Mouse)
yb206Mu01 EB病毒诱导蛋白3(EBI3)多克隆抗体 Polyclonal Antibody to Epstein Barr Virus Induced Protein 3 (EBI3) Mus musculus (Mouse)
yb207Hu01 补体成分1q子成分A(C1qA)多克隆抗体 Polyclonal Antibody to Complement Component 1, Q Subcomponent A (C1qA) Homo sapiens (Human)
yb219Hu01 胸腺素β10(TMSβ10)多克隆抗体 Polyclonal Antibody to Thymosin Beta 10 (TMSb10) Homo sapiens (Human)
yb220Mu01 胸腺旁腺素(PTMS)多克隆抗体 Polyclonal Antibody to klathymosin (PTMS) Mus musculus (Mouse)
yb221Hu01 前胸腺素α(PTMα)多克隆抗体 Polyclonal Antibody to Prothymosin Alpha (PTMa) Homo sapiens (Human)
yb223Hu01 单酰甘油脂肪酶(MGL)多克隆抗体 Polyclonal Antibody to Likle, Monoacylglycerol (MGL) Homo sapiens (Human)
yb228Hu01 快肌肌钙蛋白C(TNNC2)多克隆抗体 Polyclonal Antibody to Troponin C Type 2, Fast (TNNC2) Homo sapiens (Human)
yb229Hu01 骨骼肌慢肌肌钙蛋白I(TNNI1)多克隆抗体 Polyclonal Antibody to Troponin I Type 1, Slow Skeletal (TNNI1) Homo sapiens (Human)
yb229Ra01 骨骼肌慢肌肌钙蛋白I(TNNI1)多克隆抗体 Polyclonal Antibody to Troponin I Type 1, Slow Skeletal (TNNI1) Rattus norvegicus (Rat)
yb230Hu01 骨骼肌快肌肌钙蛋白I(TNNI2)多克隆抗体 Polyclonal Antibody to Troponin I Type 2, Fast Skeletal (TNNI2) Homo sapiens (Human)
yb230Mu01 骨骼肌快肌肌钙蛋白I(TNNI2)多克隆抗体